
Leading Oncology Cancer Type Markets Databank
Description
Leading Oncology Cancer Type Markets Databank
The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Breast cancer segment is expected to be the highest contributor to this market, with $60,659.5 Million in 2020, and is anticipated to reach $88,239.8 Million by 2029, registering a CAGR of 4.30%. Colon & rectal cancer segment is anticipated to reach $22,254.6 Million by 2029 with the highest CAGR of 4.57%. Breast cancer and Prostate cancer segments collectively expected to account for about 40.7% share of the Oncology market in 2020, with the former constituting around 22.0% share. Colon & rectal cancer and Prostate cancer segments are expected to witness significant growth rates at a CAGR of 4.57% and 4.42% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 24.2% in the overall Oncology market in 2020, and is anticipated to reach 24.5% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Breast cancer segment is expected to be the highest contributor to this market, with $60,659.5 Million in 2020, and is anticipated to reach $88,239.8 Million by 2029, registering a CAGR of 4.30%. Colon & rectal cancer segment is anticipated to reach $22,254.6 Million by 2029 with the highest CAGR of 4.57%. Breast cancer and Prostate cancer segments collectively expected to account for about 40.7% share of the Oncology market in 2020, with the former constituting around 22.0% share. Colon & rectal cancer and Prostate cancer segments are expected to witness significant growth rates at a CAGR of 4.57% and 4.42% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 24.2% in the overall Oncology market in 2020, and is anticipated to reach 24.5% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
Table of Contents
80 Pages
- 1. GLOBAL ONCOLOGY MARKET, BY CANCER TYPE
- 1.1. OVERVIEW
- 1.2. LUNG CANCER
- 1.2.1 LUNG CANCER MARKET, BY REGION
- 1.2.1.1 North America Lung cancer Market, By Country
- 1.2.1.2 Europe Lung cancer Market, By Country
- 1.2.1.3 Asia-Pacific Lung cancer Market, By Country
- 1.2.1.4 Rest of World Lung cancer Market, By Country
- 1.3. PROSTATE CANCER
- 1.3.1 PROSTATE CANCER MARKET, BY REGION
- 1.3.1.1 North America Prostate cancer Market, By Country
- 1.3.1.2 Europe Prostate cancer Market, By Country
- 1.3.1.3 Asia-Pacific Prostate cancer Market, By Country
- 1.3.1.4 Rest of World Prostate cancer Market, By Country
- 1.4. COLON & RECTAL CANCER
- 1.4.1 COLON & RECTAL CANCER MARKET, BY REGION
- 1.4.1.1 North America Colon & rectal cancer Market, By Country
- 1.4.1.2 Europe Colon & rectal cancer Market, By Country
- 1.4.1.3 Asia-Pacific Colon & rectal cancer Market, By Country
- 1.4.1.4 Rest of World Colon & rectal cancer Market, By Country
- 1.5. LIVER CANCER
- 1.5.1 LIVER CANCER MARKET, BY REGION
- 1.5.1.1 North America Liver cancer Market, By Country
- 1.5.1.2 Europe Liver cancer Market, By Country
- 1.5.1.3 Asia-Pacific Liver cancer Market, By Country
- 1.5.1.4 Rest of World Liver cancer Market, By Country
- 1.6. BREAST CANCER
- 1.6.1 BREAST CANCER MARKET, BY REGION
- 1.6.1.1 North America Breast cancer Market, By Country
- 1.6.1.2 Europe Breast cancer Market, By Country
- 1.6.1.3 Asia-Pacific Breast cancer Market, By Country
- 1.6.1.4 Rest of World Breast cancer Market, By Country
- 1.7. OTHER CANCER TYPES
- 1.7.1 OTHER CANCER TYPES MARKET, BY REGION
- 1.7.1.1 North America Other Cancer Types Market, By Country
- 1.7.1.2 Europe Other Cancer Types Market, By Country
- 1.7.1.3 Asia-Pacific Other Cancer Types Market, By Country
- 1.7.1.4 Rest of World Other Cancer Types Market, By Country
- TABLE 1. GLOBAL ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 2. LUNG CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 3. NORTH AMERICA LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 4. EUROPE LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 5. ASIA-PACIFIC LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 6. REST OF WORLD LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 7. PROSTATE CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 8. NORTH AMERICA PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 9. EUROPE PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 10. ASIA-PACIFIC PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 11. REST OF WORLD PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 12. COLON & RECTAL CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 13. NORTH AMERICA COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 14. EUROPE COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 15. ASIA-PACIFIC COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 16. REST OF WORLD COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 17. LIVER CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 18. NORTH AMERICA LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 19. EUROPE LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 20. ASIA-PACIFIC LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 21. REST OF WORLD LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 22. BREAST CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 23. NORTH AMERICA BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 24. EUROPE BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 25. ASIA-PACIFIC BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 26. REST OF WORLD BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 27. OTHER CANCER TYPES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 28. NORTH AMERICA OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 29. EUROPE OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 30. ASIA-PACIFIC OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 31. REST OF WORLD OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 1. GLOBAL ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 2. LUNG CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 3. NORTH AMERICA LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 4. EUROPE LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 5. ASIA-PACIFIC LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 6. REST OF WORLD LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 7. PROSTATE CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 8. NORTH AMERICA PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 9. EUROPE PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 10. ASIA-PACIFIC PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 11. REST OF WORLD PROSTATE CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 12. COLON & RECTAL CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 13. NORTH AMERICA COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 14. EUROPE COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 15. ASIA-PACIFIC COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 16. REST OF WORLD COLON & RECTAL CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 17. LIVER CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 18. NORTH AMERICA LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 19. EUROPE LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 20. ASIA-PACIFIC LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 21. REST OF WORLD LIVER CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 22. BREAST CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 23. NORTH AMERICA BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 24. EUROPE BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 25. ASIA-PACIFIC BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 26. REST OF WORLD BREAST CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 27. OTHER CANCER TYPES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 28. NORTH AMERICA OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 29. EUROPE OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 30. ASIA-PACIFIC OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 31. REST OF WORLD OTHER CANCER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.